Hyloris Pharmaceuticals (HYL): key financial figures for fiscal year 2025 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- €7.2M
- Net Income/Loss (FY2025)
- -€6.3M
- Total Assets (FY2025)
- €33.4M
- Total Equity (FY2025)
- €26.5M
- Cash Flows from Operating Activities (FY2025)
- -€7.0M
Source: Hyloris Pharmaceuticals annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
